Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication

R J Lederman1, A N Tenaglia, R D Anderson

  • 1Department of Internal Medicine, Division of Cardiology, University of Michigan Health System, Ann Arbor, Michigan, USA.